In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 109 for your search:
Cancer Type/Condition:  Brain tumor, child: Other
Trial Type:  Treatment
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase III, Phase II
Type: Treatment
Status: Approved-not yet active
Age: At least 3 to 5 years to under 22 years
Sponsor: Other
Protocol IDs: SIOP PNET 5 MB, 2011-004868-30, NCT02066220

2.

Phase: Phase III
Type: Supportive care, Treatment
Status: Active
Age: 3 to 21 at diagnosis
Sponsor: NCI, Other
Protocol IDs: ACNS0331, COG-ACNS0331, CDR0000365506, NCT00085735

3.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 1 to 21
Sponsor: NCI, Other
Protocol IDs: ACNS0831, NCI-2011-02029, COG-ACNS0831, CDR0000668560, U10CA098543, NCT01096368

4.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 50 and under
Sponsor: NCI, Other
Protocol IDs: AEWS1031, NCI-2011-02611, COG-AEWS1031, CDR0000687639, U10CA098543, NCT01231906

5.

Phase: Phase III
Type: Treatment
Status: Active
Age: 2 to 18
Sponsor: Other
Protocol IDs: CCHE-BT002, NCT01878266

6.

Phase: Phase III
Type: Treatment
Status: Approved-not yet active
Age: 1 to 25
Sponsor: NCI, Other
Protocol IDs: 2013-062, NCI-2013-02001, P30CA022453, NCT01987596

7.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 2 to 32
Sponsor: Pharmaceutical / Industry
Protocol IDs: CNS 0201, NCT00179907

8.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 1 to 21
Sponsor: NCI, Other
Protocol IDs: ADVL0912, COG-ADVL0912, CDR0000647587, NCT00939770

9.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 1 to 30
Sponsor: Other
Protocol IDs: OHSU-5056, SOL-08131-L, NCT00983398

10.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 12 to 21
Sponsor: NCI
Protocol IDs: NCI-2012-03173, CDR667932, PBTC-029B, PBTC-029, U01CA081457, NCT01089101

11.

Phase: Phase II, Phase I
Type: Treatment
Status: Approved-not yet active
Age: 3 to 75
Sponsor: Other
Protocol IDs: NDV-HUJ-HMO-CTIL, NCT01174537

12.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 2 to 18
Sponsor: Pharmaceutical / Industry
Protocol IDs: DFI12860, 2010-019340-40, MOZ15609, NCT01288573

13.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 4 to 21
Sponsor: Other
Protocol IDs: 10-096, NCT01294670

14.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 21 and under
Sponsor: Other
Protocol IDs: Re-MATCH, W81XWH-10-1-0089, CDMRP-PRO93877, NCT01326104

15.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 21 and under
Sponsor: NCI
Protocol IDs: NCI-2012-00082, 12-C-0213, CDR0000717423, P12978, PBTC-033, U01CA081457, NCT01514201

16.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 17 and under
Sponsor: Other
Protocol IDs: 2011-0804, NCI-2011-03725, NCT01469247

17.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: Over 12 months to 30 years
Sponsor: Pharmaceutical / Industry
Protocol IDs: NMTRC 004, NCT01483820

18.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 12 and over
Sponsor: Other
Protocol IDs: 2010-0700, NCI-2012-00788, NCT01590069

19.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 3 and over
Sponsor: Other
Protocol IDs: 2011-0844, NCI-2012-00849, NCT01596127

20.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 2 to 18
Sponsor: Pharmaceutical / Industry
Protocol IDs: TED12689, U1111-1128-5704, NCT01751308

21.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 1 to 22
Sponsor: Other
Protocol IDs: 027812-HMO-CTIL, NCT01777633

22.

Phase: Phase II, Phase I
Type: Treatment
Status: Approved-not yet active
Age: 21 and under
Sponsor: Other
Protocol IDs: CCMC1311, NCT01837862

23.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: Under 22
Sponsor: Other
Protocol IDs: 1202012214, NCT01884740

24.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 3 to 90
Sponsor: Other
Protocol IDs: antiPD1brainad, NCT01952769

25.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 5 and under
Sponsor: Other
Protocol IDs: 2012-004842-14, 2012/1908, NCT02025881
1     
New Search